Two Studies Map How Protein Patterns in Melanoma Tumors Affect Treatment Response
Key Highlights
- Two studies in Cancer Discovery and Clinical Cancer Research examined tumor proteins to better understand melanoma immunotherapy outcomes.
- A molecular atlas identified protein alterations associated with patient survival and potential targets for future drugs.
- Analysis of 208 pretreatment tumor samples revealed immune-rich, proliferative, and growth-and-metastasis subtypes.
- A classifier based on protein patterns predicted immunotherapy response type and progression-free survival.



